Target to patient

  • Sunday, 8 May 2022 - Tuesday, 10 May 2022
Organised by the European Bioinformatics Institute (EBI) with support from the Society for Medicines Research

Advances in genomics, in vitro technologies, data analysis and digital health are transforming our understanding of disease leading to an explosion of new opportunities in drug discovery. Join this meeting to hear scientific leaders explore how these advances are being used to identify new drug targets and create opportunities for improved clinical trials design.

The Wellcome Genome Campus, Hinxton, UK. CB10 1RQ

OR online via their conference portal

Find out more here

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.